Aprepitant 40 mg Prescription Drug Recalled for Manufacturing Temperature Deviations
McKesson Medical-Surgical is recalling 29 boxes of Aprepitant 40 mg capsules nationwide due to temperature abuse during manufacturing that violated current Good Manufacturing Practice standards.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall for manufacturing process deviations without reported illnesses or injuries. Temperature abuse affecting drug stability is a quality issue rather than a direct safety hazard.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling 29 boxes of Aprepitant 40 mg capsules distributed nationwide. The recall was initiated due to manufacturing process deviations identified as temperature abuse that did not conform to current Good Manufacturing Practice (cGMP) standards.
Aprepitant is a prescription medication used to prevent nausea and vomiting. The temperature abuse during manufacturing may have affected the drug's stability. No illnesses or injuries have been reported associated with this recall.
Consumers should contact their pharmacy or healthcare provider if they have this product. Patients should not stop taking their medication without consulting their doctor.
The recalled product
- Product
- APREPITANT (APREPITANT)
- Brand
- APREPITANT
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug
- Hazard
- cGMP-deviation
- temperature-abuse
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27